Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: An alternative therapy for patients with major depressive disorder

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Hernandez, María Eugenia ^a,b   Mendieta, Danelia ^a   Pérez Tapia, Mayra ^c   Bojalil, Rafael ^d   Estrada Garcia, Iris ^c   Estrada Parra, Sergio ^c   Pavón, Lenin ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESCITALOPRAM; FLUOXETINE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEUKOCYTE EXTRACT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANFERON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; IMMUNOLOGIC FACTOR;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE URINE LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; METABOLISM; TREATMENT OUTCOME; URINE;

ADULT; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; MALE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84890074100     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/267871     Document Type: Article

References (61)

1. Kendler K. S., Thornton L. M., Gardner C. O., Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. American Journal of Psychiatry 2000 157 8 1243 1251 2-s2.0-0033847668 10.1176/appi.ajp.157.8.1243 (Pubitemid 30662071)
2. Kessler R. C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K. R., Rush A. J., Walters E. E., Wang P. S., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). The Journal of the American Medical Association 2003 289 23 3095 3105 2-s2.0-0037831023 10.1001/jama.289.23.3095 (Pubitemid 37432885)
3. World Health Organization, The Global Burden of Disease 2004 Update 2008 World Health Organization
4. World Health Organization, Investing in mental health. World Health Organization, 2003, http://www.who.int/mental-health/en/
5. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B., Depression, chronic diseases, and decrements in health: results from the World Health Surveys. The Lancet 2007 370 9590 851 858 2-s2.0-34548396844 10.1016/S0140-6736(07)61415-9 (Pubitemid 47362344)
6. Pariante C. M., Miller A. H., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 2001 49 5 391 404 2-s2.0-0035280252 10.1016/S0006-3223(00)01088-X (Pubitemid 32234301)
7. Holsboer F., The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000 23 5 477 501 2-s2.0-0033797445 10.1016/S0893- 133X(00)00159-7
8. Silverman M. N., Sternberg E. M., Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Annals of the New York Academy of Sciences 2012 1261 55 63
9. Besedovsky H., Del Rey A., Lajtha A., Brain cytokines as integrators of the immune-neuroendocrine network. Handbook of Neurochemistry and Molecular Neurobiology 2008 Springer
10. Zunszain P. A., Anacker C., Cattaneo A., Carvalho L. A., Pariante C. M., Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 722 729 2-s2.0-79954612444 10.1016/j.pnpbp.2010.04.011
11. Kronfol Z., Immune dysregulation in major depression: a critical review of existing evidence. International Journal of Neuropsychopharmacology 2002 5 4 333 343 2-s2.0-0036902057 10.1017/S1461145702003024 (Pubitemid 35470354)
12. Felger J. C., Lotrich F. E., Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013 246 199 229
13. Axelson D. A., Doraiswamy P. M., McDonald W. M., Boyko O. B., Tupler L. A., Patterson L. J., Nemeroff C. B., Ellinwood E. H. Jr., Krishnan K. R. R., Hyperocortisolemia and hippocampal changes in depression. Psychiatry Research 1993 47 2 163 173 2-s2.0-0027335570 10.1016/0165-1781(93)90046-J (Pubitemid 23174043)
14. Huber T. J., Issa K., Schik G., Wolf O. T., The cortisol awakening response is blunted in psychotherapy inpatients suffering from depression. Psychoneuroendocrinology 2006 31 7 900 904 2-s2.0-33745226456 10.1016/j.psyneuen.2006.03.005 (Pubitemid 43928294)
15. Nikisch G., Mathé A. A., Czernik A., Thiele J., Bohner J., Eap C. B., Ågren H., Baumann P., Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology 2005 181 4 751 760 2-s2.0-25844518335 10.1007/s00213-005-0034-3 (Pubitemid 41400761)
16. Bhagwagar Z., Whale R., Cowen P. J., State and trait abnormalities in serotonin function in major depression. British Journal of Psychiatry 2002 180 24 28 2-s2.0-0036153274 10.1192/bjp.180.1.24 (Pubitemid 34093621)
17. Kupfer D. J., Long-term treatment of depression. Journal of Clinical Psychiatry 1991 52 supplement 5 28 34 2-s2.0-0025865067
18. Okuyama-Tamura M., Mikuni M., Kojima I., Modulation of the human glucocorticoid receptor function by antidepressive compounds. Neuroscience Letters 2003 342 3 206 210 2-s2.0-0037693718 10.1016/S0304-3940(03)00261-1 (Pubitemid 36570353)
19. Pariante C. M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A. H., Kerwin R. W., Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. British Journal of Pharmacology 2001 134 6 1335 1343 2-s2.0-0035197083 (Pubitemid 33097265)
20. Hernández M. E., Mendieta D., Martínez-Fong D., Loría F., Moreno J., Estrada I., Bojalil R., Pavón L., Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. European Neuropsychopharmacology 2008 18 12 917 924 2-s2.0-53649099619 10.1016/j.euroneuro.2008.08.001
21. Pavon L., Sandoval-Lopez G., Eugenia Hernandez M., Loria F., Estrada I., Perez M., Moreno J., Avila U., Leff P., Anton B., Heinze G., Th2 cytokine response in major depressive disorder patients before treatment. Journal of Neuroimmunology 2006 172 156 165 (Pubitemid 43277501)
22. Pompili M., Venturini P., Palermo M., Stefani H., Seretti M. E., Lamis D. A., Serafini G., Amore M., Girardi P., Mood disorders medications: predictors of nonadherence-review of the current literature. Expert Review of Neurotherapeutics 2013 13 7 809 825
23. Medina-Rivero E., Merchand-Reyes G., Pavón L., Vázquez-Leyva S., Pérez-Sánchez G., Salinas-Jazmín N., Estrada-Parra S., Velasco-Velázquez M., Pérez-Tapia S. M., Batch-to-batch reproducibility of transferon. Journal of Pharmaceutical and Biomedical Analysis 2014 88 289 294 10.1016/j.jpba.2013.09.004
24. Byston J., Cech K., Pekarek J., Jilkova J., Effect of anti-herpes specific transfer factor. Biotherapy 1996 9 1-3 73 75 2-s2.0-0029750484 (Pubitemid 26421196)
25. Pizza G., De Vinci C., Conte G. L., Maver P., Dragoni E., Aiello E., Fornarola V., Bergami T., Busutti L., Boriani S., Palareti A., Capanna R., Immunotherapy of metastatic kidney cancer. International Journal of Cancer 2001 94 1 109 120 2-s2.0-17944377947 10.1002/ijc.1426 (Pubitemid 32801759)
26. Franco-Molina M. A., Mendoza-Gamboa E., Castillo-León L., Tamez-Guerra R. S., Rodríguez-Padilla C., Bovine dialyzable leukocyte extract modulates the nitric oxide and proinflammatory cytokine production in lipopolysaccharide-stimulated murine peritoneal macrophages in vitro. Journal of Medicinal Food 2005 8 1 20 26 2-s2.0-18144427475 10.1089/jmf.2005.8.20 (Pubitemid 40617032)
27. Berrón-Pérez R., Chávez-Sánchez R., Estrada-García I., Espinosa-Padilla S., Cortez-Gómez R., Serrano-Miranda E., Ondarza-Aguilera R., Pérez-Tapia M., Pineda Olvera B., Jiménez-Martínez M. D. C., Portugués A., Rodríguez A., Cano L., Pacheco P. U., Barrientos J., Chacón R., Serafín J., Mendez P., Monges A., Cervantes E., Estrada-Parra S., Indications, usage, and dosage of the transfer factor. Revista Alergia Mexico 2007 54 4 134 139 2-s2.0-47049109918
28. Sapolsky R. M., Plotsky P. M., Hypercortisolism and its possible neural bases. Biological Psychiatry 1990 27 9 937 952 2-s2.0-0025246034 10.1016/0006-3223(90)90032-W (Pubitemid 20134206)
29. McEwen B. S., Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression. Dialogues in Clinical Neuroscience 2004 6 2 119 133 2-s2.0-3042818132 (Pubitemid 38886186)
30. Plotsky P. M., Owens M. J., Nemeroff C. B., Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America 1998 21 2 293 307 2-s2.0-0031807854 10.1016/S0193-953X(05)70006-X (Pubitemid 28311852)
31. Schüle C., Baghai T. C., Eser D., Schwarz M., Bondy B., Rupprecht R., Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. Journal of Psychiatric Research 2009 43 5 538 545 2-s2.0-59649097238 10.1016/j.jpsychires.2008.07.003
32. Mössner R., Lesch K.-P., Role of serotonin in the immune system and in neuroimmune interactions. Brain, Behavior, and Immunity 1998 12 4 249 271 2-s2.0-0344004854 10.1006/brbi.1998.0532 (Pubitemid 29224829)
33. Färber L., Haus U., Späth M., Drechsler S., Physiology and pathophysiology of the 5-HT3 receptor. Scandinavian Journal of Rheumatology, Supplement 2004 33 119 2 8 2-s2.0-4444356077 10.1080/03009740410006943 (Pubitemid 39180178)
34. Sternberg E. M., Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Reviews Immunology 2006 6 4 318 328 2-s2.0-33645284772 10.1038/nri1810
35. Blardi P., De Lalla A., Leo A., Auteri A., Iapichino S., Di Muro A., Dell'Erba A., Castrogiovanni P., Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients. Journal of Clinical Psychopharmacology 2002 22 2 131 136 2-s2.0-0036219170 10.1097/00004714- 200204000-00005 (Pubitemid 34289387)
36. Bschor T., Ising M., Erbe S., Winkelmann P., Ritter D., Uhr M., Lewitzka U., Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients. Journal of Psychiatric Research 2012 46 1 111 117 2-s2.0-81855197087 10.1016/j.jpsychires.2011.09.020
37. Pariante C. M., Kim R. B., Makoff A., Kerwin R. W., Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. British Journal of Pharmacology 2003 139 6 1111 1118 2-s2.0-0042168887 10.1038/sj.bjp.0705357 (Pubitemid 36920673)
38. Spijker A. T., van Rossum E. F. C., Glucocorticoid sensitivity in mood disorders. Neuroendocrinology 2012 95 3 179 186 2-s2.0-80755126618 10.1159/000329846
39. Carvalho L. A., Juruena M. F., Papadopoulos A. S., Poon L., Kerwin R., Cleare A. J., Pariante C. M., Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology 2008 33 13 3182 3189 2-s2.0-57349088150 10.1038/npp.2008.44
40. Contesse V., Lefebvre H., Lenglet S., Kuhn J.-M., Delarue C., Vaudry H., Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells. Canadian Journal of Physiology and Pharmacology 2000 78 12 967 983 2-s2.0-0034495054 10.1139/cjpp-78-12-967 (Pubitemid 32109428)
41. Delarue C., Contesse V., Lefebvre H., Lenglet S., Grumolato L., Kuhn J. M., Vaudry H., Pharmacological profile of serotonergic receptors in the adrenal gland. Endocrine Research 1998 24 3-4 687 694 2-s2.0-0032428006 (Pubitemid 29016462)
42. Johnson D. A., Grant E. J., Ingram C. D., Gartside S. E., Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biological Psychiatry 2007 62 11 1228 1235 2-s2.0-35848945707 10.1016/j.biopsych.2007.05.003 (Pubitemid 350060897)
43. Johnson D. A., Ingram C. D., Grant E. J., Craighead M., Gartside S. E., Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter. Neuropsychopharmacology 2009 34 2 399 409 2-s2.0-57849127923 10.1038/npp.2008.70
44. Thakore J. H., Barnes C., Joyce J., Medbak S., Dinan T. G., Effects of antidepressant treatment on corticotropin-induced cortisol responses in patients with melancholic depression. Psychiatry Research 1997 73 1-2 27 32 2-s2.0-0031567742 10.1016/S0165-1781(97)00106-6 (Pubitemid 28032205)
45. González A., Fazzino F., Castillo M., Mata S., Lima L., Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients. NeuroImmunoModulation 2007 14 1 8 15 2-s2.0-34548332488 10.1159/000107283 (Pubitemid 47340630)
46. Mizrahi C., Stojanovic A., Urbina M., Carreira I., Lima L., Differential cAMP levels and serotonin effects in blood peripheral mononuclear cells and lymphocytes from major depression patients. International Immunopharmacology 2004 4 8 1125 1133 2-s2.0-3042568773 10.1016/j.intimp.2004.05.001 (Pubitemid 38844188)
47. Gormley G. J., Lowy M. T., Reder A. T., Hospelhorn V. D., Antel J. F., Meltzer H. Y., Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. American Journal of Psychiatry 1985 142 11 1278 1284 2-s2.0-0022358054 (Pubitemid 16216563)
48. Lowy M. T., Reder A. T., Gormley G. J., Meltzer H. Y., Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppresion test. Biological Psychiatry 1988 24 6 619 630 2-s2.0-0023766021
49. Lima L., Urbina M., Serotonin transporter modulation in blood lymphocytes from patients with major depression. Cellular and Molecular Neurobiology 2002 22 5-6 797 804 2-s2.0-0036973402 10.1023/A:1021869310702 (Pubitemid 36169225)
50. Kubera M., Maes M., Kenis G., Kim Y.-K., Lasoń W., Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6. Psychiatry Research 2005 134 3 251 258 2-s2.0-18844378658 10.1016/j.psychres.2004.01.014 (Pubitemid 40693942)
51. Elenkov I. J., Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochemistry International 2008 52 1 40 51 2-s2.0-36849037934 10.1016/j.neuint.2007.06.037 (Pubitemid 350235704)
52. Kim Y. K., Na K. S., Shin K. H., Jung H. Y., Choi S. H., Kim J. B., Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007 31 5 1044 1053
53. Kim Y.-K., Lee S.-W., Kim S.-H., Shim S.-H., Han S.-W., Choi S.-H., Lee B.-H., Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008 32 2 356 361 2-s2.0-38749084587 10.1016/j.pnpbp.2007. 08.041 (Pubitemid 351178950)
54. Kubera M., Kenis G., Bosmans E., Scharpé S., Maes M., Effects of serotonin and serotonergic agonists and antagonists on the production of interferon- γ and interleukin-10. Neuropsychopharmacology 2000 23 1 89 98 2-s2.0-0034047297 10.1016/S0893-133X(99)00150-5 (Pubitemid 30408315)
55. Hannestad J., Dellagioia N., Bloch M., The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011 36 12 2452 2459 2-s2.0-80054745701 10.1038/npp.2011.132
56. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kühn M., Schuld A., Pollmächer T., Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. Journal of Psychiatric Research 1999 33 5 407 418 2-s2.0-0032790648 10.1016/S0022-3956(99)00021-7 (Pubitemid 29392689)
57. Basten A., Pollard J. D., Stewart J. G., Transfer factor in treatment of multiple sclerosis. The Lancet 1980 2 8201 931 934 2-s2.0-0019163011 (Pubitemid 11240456)
58. Estrada-Parra S., Nagaya A., Serrano E., Rodriguez O., Santamaria V., Ondarza R., Chavez R., Correa B., Monges A., Cabezas R., Calva C., Estrada-Garcia I., Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. International Journal of Immunopharmacology 1998 20 10 521 535 2-s2.0-0031767956 10.1016/S0192-0561(98)00031-9 (Pubitemid 28529385)
59. Pilotti V., Mastrorilli M., Pizza G., De Vinci C., Busutti L., Palareti A., Gozzetti G., Cavallari A., Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy 1996 9 1-3 117 121 2-s2.0-0029751813 (Pubitemid 26421204)
60. Krutzik S. R., Tan B., Li H., Ochoa M. T., Liu P. T., Sharfstein S. E., Graeber T. G., Sieling P. A., Liu Y.-J., Rea T. H., Bloom B. R., Modlin R. L., TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nature Medicine 2005 11 6 653 660 2-s2.0-20944442160 10.1038/nm1246 (Pubitemid 40868306)
61. Lancaster G. I., Khan Q., Drysdale P., Wallace F., Jeukendrup A. E., Drayson M. T., Gleeson M., The physiological regulation of toll-like receptor expression and function in humans. Journal of Physiology 2005 563 3 945 955 2-s2.0-15844366621 10.1113/jphysiol.2004.081224 (Pubitemid 40425607)